Fully automated spleen segmentation predicts progression-free survival in HCC patients following transarterial radioembolization
Automated splenic volumetry showed superior prognostic value over traditional markers in HCC patients treated with TARE. A post-treatment increase in spleen volume represents an additional, robust, and readily accessible imaging biomarker for early risk stratification and individualized treatment planning.
Authors
- Ursula Ehmer
- Karina Knorr (ORCID: https://orcid.org/0000-0003-2022-4805)
- Jannis Bodden (ORCID: https://orcid.org/0000-0001-5997-203X)
- Bernhard Haller (ORCID: https://orcid.org/0000-0002-9723-393X)
- Matthias Eiber (ORCID: https://orcid.org/0000-0003-2654-6872)
- Lukas Endroes
- Noemi Schweizer
- Friederike Jungmann
- Henrik Einwächter
- Robert Walter
- Manuel Nickel
- Rickmer Braren
- Christopher Spaeth
- Lisa Steinhelfer
Institutions
- Universität Hamburg (DE)
- TUM Klinikum (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- German Centre for Cardiovascular Research (DE)
- Tumkur University (IN)
- Technical University of Munich (DE)
Publication Details
- Journal
- European Journal of Nuclear Medicine and Molecular Imaging
- Published
- 2026-02-17
- DOI
- https://doi.org/10.1007/s00259-026-07792-8
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00